A patient is started on sertraline (Zoloft), an SSRI, for depression. Education regarding this class of medications includes:

Selective serotonin reuptake inhibitors (SSRIs) such as Sertraline (Zoloft) are commonly used first-line treatments for major depressive disorder. These medications work by increasing serotonin availability in the central nervous system, improving mood and anxiety symptoms over time. Unlike acute symptom-relief medications, SSRIs require consistent daily use and a delayed onset of full therapeutic effect. Patient education is essential to set realistic expectations and improve adherence during the initial treatment period. Rationale: A. Red-green color blindness is not associated with Sertraline (Zoloft). SSRIs do not affect retinal cone function or visual color processing pathways. Visual disturbances are not a recognized class effect, and this reflects a misconception unrelated to SSRI pharmacology or safety profile. B. SSRIs such as Sertraline (Zoloft) typically require 4–8 weeks to achieve maximum therapeutic effect because neurochemical and receptor adaptations in the brain take time. While some early improvement in sleep or anxiety may occur, full antidepressant effects are delayed. Educating patients about this timeline helps prevent premature discontinuation due to perceived lack of benefit. C. Chest pain is not a common or expected adverse effect of Sertraline (Zoloft) and should not be managed with aspirin as a routine response. Chest pain should always be evaluated for potential cardiac or other serious causes rather than attributed to SSRI therapy. D. Probiotics are not part of standard education for preventing diarrhea related to Sertraline (Zoloft). While mild gastrointestinal upset such as nausea or diarrhea may occur initially with SSRIs, these symptoms usually resolve over time without specific probiotic therapy. Management is typically supportive and focused on tolerance rather than routine supplementation.